Sep
30
Tue
Cancer Educ Seminar: Simulation Modeling of Lung and Breast Cancer Outcomes @ Stanford Cancer Center CC 2103-2104
Sep 30 @ 8:00 am – 9:00 am
Cancer Educ Seminar: Simulation Modeling of Lung and Breast Cancer Outcomes @ Stanford Cancer Center CC 2103-2104

Presenter: Sylvia Plevritis, PhD, Professor of Radiology (General Radiology)

Nov
17
Tue
Cancer Education Seminar: Immunotherapy in Lung Cancer and Forum: Right to Die Legislation @ Cancer Center, CC 2103-05
Nov 17 @ 8:00 am – 9:00 am
Cancer Education Seminar: Immunotherapy in Lung Cancer and Forum: Right to Die Legislation @ Cancer Center, CC 2103-05 | Palo Alto | California | United States

Presenters: Suki Padda, MD, Instructor of Medicine (Oncology): “Immunotherapy in Lung Cancer.” Kavitha Ramchandran, MD, Clinical Assistant Professor of Medicine (Oncology): “Forum Discussion of Right to Die Legislation”.

Nov
24
Tue
Cancer Education Seminar: Survivorship and Surveillance for NSCLC @ Cancer Center, CC 2103-05
Nov 24 @ 8:00 am – 9:00 am
Cancer Education Seminar: Survivorship and Surveillance for NSCLC @ Cancer Center, CC 2103-05 | Palo Alto | California | United States

Presenter: Leah Backhus, MD, Associate Professor of Cardiothoracic Surgery (Thoracic Surgery)

Apr
10
Wed
Medicine Grand Rounds Blume Memorial Lecture: Twenty-five years of Progress in the Clinical Art of Hematopoietic Cell Transplantation @ LKSC Berg Hall
Apr 10 @ 8:00 am – 9:00 am
Medicine Grand Rounds Blume Memorial Lecture: Twenty-five years of Progress in the Clinical Art of Hematopoietic Cell Transplantation @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Fred Appelbaum, MD

Professor of Medical Oncology, University of Washington

Executive Vice President and Deputy Director, External Affairs, Fred Hutchinson Cancer Research Center

Dr. Appelbaum is the executive director of SCCA. His work centers on the biology and treatment of acute myeloid leukemia.

Decades of working with cancer patients teaches you to savor everyday pleasures like the teasing notes of coriander and cumin in a simmering pot of curry or getting to hug your child, and it fortifies his resolve to keep moving cancer care forward. He’s determined to improve screening, enhance treatment and stop cancer from returning.

As a medical student in the early 1970s, Dr. Appelbaum happened upon Dr. E. Donnall Thomas’ initial description of bone-marrow transplantation in a medical journal. The pioneering technique eventually earned Thomas the Nobel Prize and transformed leukemia and related cancers, once thought incurable, into highly treatable diseases with survival rates as high as 90 percent.

Bone-marrow transplants became the cornerstone of the newly formed Hutchinson Center, and it wasn’t long before Dr. Appelbaum was recruited to join Thomas’ team of medical mavericks in Seattle making historic inroads against blood cancers.

Now, he holds the job that Thomas once held, and he has spent decades building on Thomas’ groundbreaking innovations. Dr. Appelbaum has been an innovator in his own right, refining transplant procedures, conducting clinical trials and caring for patients.

Part of that job is extending the Hutch’s patient research beyond transplants. We’ve expanded our role in the more common solid tumors and have created nontransplant approaches to blood cancers. We’ve made substantial gains in treating prostate, colon, pancreatic, lung, breast and ovarian cancers, but we have a long way to go.